M. Rasing
Papers
1
Total Citations
2
H-Index
1
About
M. Rasing is a pioneering researcher in interventional oncology, specializing in the integration of robotics and magnetic resonance imaging (MRI) for precision cancer treatments. Their most significant contribution is the development of the ROBiNSon system—a robotic device designed for MR-guided high-dose-rate (HDR) brachytherapy needle implantation in the prostate. In their landmark 2024 proof-of-concept study, Rasing demonstrated the feasibility and spatial accuracy of this robotic approach for targeting a single intraprostatic point, marking a critical step toward fully automated, MRI-compatible brachytherapy. This work addresses a major clinical challenge: improving needle placement precision while minimizing patient trauma and radiation exposure to staff. Although early in its citation history (2 citations), the study has already established Rasing as a key innovator at the intersection of medical robotics and radiation oncology. Their research promises to enhance the accuracy and reproducibility of HDR brachytherapy, potentially transforming prostate cancer treatment by enabling more targeted, less invasive interventions. Rasing’s work is foundational for future clinical translation of robotic systems in interventional MRI.
Research Focus
Key Achievements
Top Papers
- 1